All 1 tracked stories fall under one category: clinical-trial. British National Health Service (NHS) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Uterine Factor Infertility (UFI) appears in 1 tracked Biotech story from February 24, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Uterine Factor Infertility (UFI)
All 1 tracked stories fall under one category: clinical-trial. British National Health Service (NHS) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Uterine Factor Infertility (UFI) appears in 1 tracked Biotech story from February 24, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Uterine Factor Infertility (UFI). Shared-story counts are live from our verified record — not editorial picks.
The United Kingdom has recorded its first birth from a mother who received a womb transplant from a deceased donor, a landmark achievement for the NHS. This breakthrough expands the possibilities for treating uterine factor infertility and reduces the surgical risks associated with living donor procedures.
Uterine Factor Infertility (UFI) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.